Safety and efficacy of procainamide infusions
- 31 January 1979
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 43 (1), 98-105
- https://doi.org/10.1016/0002-9149(79)90051-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotypeJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Pharmacokinetics of isoniazid metabolism in manJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Pharmacokinetics in man of theN-acetylated metabolite of proeainamideJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Elimination rate ofN-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in manJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Electrophysiologic properties of procainamide in manThe American Journal of Cardiology, 1974
- Electrophysiologic Effects of Procaine Amide in Patients with Intraventricular Conduction DelayCirculation, 1974
- Treatment of myocardial infarction in a coronary care unitThe American Journal of Cardiology, 1967
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960
- Ventricular standstill during the intravenous procaine amide treatment of ventricular tachycardiaAmerican Heart Journal, 1953